All procedures for animal experiments were approved by the IACUC (#07212) at Clinical research institute, Seoul National University Hospital. Experiments were performed in accordance with NIH guidelines. We assessed whether ITSFn-cultured cells are bipotential in vivo by evaluating their fate after engraftment to three immune-deficient NOD-SCID mice (male; N=3). CN cells (1×105) and SVZ-derived NSCs (1×105) were transplanted four weeks after primary culture to assess their lineage potential after transplantation (1×105 cells per ml) along the anterior-posterior axis into the target brain at these coordinates: from the bregma, 2 mm anteriorly, 3 mm laterally and to 5 mm depth. The cells were live-stained with DiI (Invitrogen) delivered by an infusion pump at 0.5 ml/min. The needle was left in situ for 2 min post-injection before being slowly removed. The recipients were sacrificed and fixed four weeks after transplantation.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.